* News & Events *

 

There’s no better feeling when you run a client services agency than to identify a need and be able to deliver a solution. We get to do that today, with the introduction of Reimbursography, GLOBALHealthPR’s global strategic communications programme that leverages country-specific access insights to shape the value context for reimbursement success.

GLOBALHealthPR clients discover some of the world’s most innovative treatments for life-threatening conditions, saving and improving lives around the globe. They invest billions of dollars in the science and in the people who develop treatments for cancer, infectious and cardiovascular diseases, and more. Yet when their drugs make it through regulatory approvals, they face huge hurdles in global market access and reimbursement. A treatment’s value to the patient, to the community, to the healthcare system as a whole, is reduced to a discussion – usually an overwhelmingly contentious one – about the cost of the prescription.

But price is not really the issue here. It’s about recognition – by all decision makers – of the value that a new treatment brings to the market. To achieve that recognition, you need to build and tell a compelling and credible value story.

In our inaugural Reimbursography white paper, “Pharma Market Access Success: Shifting the Dialogue from Price to Value Through Strategic Communications,” we demonstrate how communications creates the right environment for value recognition.

Market Demand for a New Approach

At GLOBALHealthPR we see an opportunity to redefine market access communications, building the story early in the drug development process and sustaining it throughout the product lifecycle. Clients have increasingly turned to us for help with market access challenges. In the countries where we live and work, GLOBALHealthPR partners have seen restrictions attached to reimbursement agreements and reluctance of companies to even launch a product in some markets. Reimbursography reflects our collective capabilities to substantiate and communicate the value of an innovative treatment for funding, access, coverage and reimbursement in markets around the world.

 

What Makes GLOBALHealthPR Stand Out When it Comes to Market Access Communications

• We are a connected global network that works effectively and efficiently in key geographies around the world. Check out our high-level market access and reimbursement insights for key markets in our Reimbursography guides.
• Our partnership includes expertise in health communications, PhD scientists, best-in-class market access consultants and trusted counselors with in-country experience and relationship
• We engage clients to conduct a value analysis and bring together company cross-functional leaders and key market access stakeholders for an open dialog about value, to ultimately arrive at a customised value communications playbook.

Download the white paper and get in touch with GLOBALHealthPR to learn how Reimbursography can help tell your product’s story to showcase its value to the marketplace.

With offices in Toronto and Montreal, energi expands GLOBALHealthPR presence to 38 markets

 

TORONTO, ONTARIO–(Marketwired – May 5, 2015) – energi PR announced today that it has been chosen as the newest partner in GLOBALHealthPR, the largest independent agency partnership worldwide dedicated to health and medical communications. energi PR will be the sole Canadian partner, adding its Toronto and Montreal offices to GLOBALHealthPR’s growing presence in 38 countries, spanning five continents.”GLOBALHealthPR is excited to add energi PR to our best-in-class partnership of independent health and science communications agencies worldwide,” said John Seng, Chair of GLOBALHealthPR. “Our partnership is grounded in a deep understanding of local, regional and global trends and an ability to translate complex science into simple stories. With the addition of energi PR, a proven leader in health and medical communications, our global clients gain access to unrivaled insights, strategy and execution across Canada, and in its two official languages.”Headquartered in New York, with regional hub company offices in London and Singapore, GLOBALHealthPR is a partnership of independently owned and operated health and science communications agencies that choose to work together based on common values. With more than 600 health-specialist communications professionals and more than 100 PhDs, researchers and medical advisors on staff, the agencies that make up the partnership share a belief in insights-driven strategies and a commitment to collaboration in order to provide clients the best possible counsel and execution.”energi PR is delighted to be welcomed by the partners of GLOBALHealthPR,” said Carol Levine, CEO and co-founder of energi PR. “Pharmaceutical, medical device companies, health and wellness organizations and professional associations can expect best-in-market communications expertise through GLOBALHealthPR and energi PR,” she said. “Opening up real-time access to GHPR’s huge network of health communications professionals will allow us to offer unparalleled expertise and bench-strength that is targeted to our core business.”

Marlo Taylor, energi PR Partner and head of its healthcare practice added, “the healthcare and pharmaceutical industry is an important and continually evolving sector in Canada. Being a member of GLOBALHealthPR, which currently serves more than two-thirds of the top 50 pharmaceutical companies, we will be able to help more of these companies achieve their science and story-telling objectives in Canada, while also leveraging potential cross-market synergies.”

About GLOBALHealthPR

GLOBALHealthPR, founded in 2001 by Chair John Seng, consists of leading, health-focused, independent public relations agencies in 38 countries, including Argentina, Australia, Brazil, Canada, China, Germany, India, Indonesia, Italy, Malaysia, Mexico, Mozambique, Myanmar, Poland, Portugal, Qatar, Singapore, South Korea, Spain, Switzerland, Thailand, the United Kingdom, the United States and Vietnam. GLOBALHealthPR is headquartered in New York at Spectrum Science Communications. For more information, visit www.globalhealthpr.com or follow us on Twitter: @GLOBALHealthPR.

About energi PR

Founded in 1990, energi PR is a bilingual, independently-owned agency specializing in public relations, social media/digital and corporate communications. With offices in Toronto and Montreal, energi PR delivers integrated public relations services to national and multi-national clients. Pharmaceutical, wellness and consumer health communications has been a core strategic practice area since the inception of the agency. energi PR is a founding member of the Canadian Council of Public Relations Firms. To learn more, visit energipr.com or follow us on Facebook and Twitter: @energiPR.

We’re thrilled to share the news that Mr. Yap Boh Tiong of GLOBALHealthPR Singapore partner, Mileage Communications, has been awarded the prestigious Established Entrepreneur of the Year 2014 Award. The Entrepreneur of the Year Award is the oldest award in Singapore that salutes and honors local entrepreneurs who have shown outstanding performance as business owners in their chosen field of entrepreneurship. This year marks the 26^th annual edition of the awards.

[Read more…] about A Milestone for Mr. Yap Boh Tiong of Mileage Communications

When it comes to international public relations, the right collaboration can change lives. That’s the word from GLOBALHealthPR Chair, John Seng, who was featured in this month’s global issue of O’Dwyer’s, the United States’ leading publication for PR and marketing communications professionals.

Seng’s article highlights the value of a healthcare-only network of independent communications agencies and how this model provides the reach and local insights to impact patients’ lives through innovative campaigns. [Read more…] about Why Global PR Matters

Today’s blog post comes to us from Dinesh Chindarkar, Co-Founder of our GLOBALHealthPR India partner, MediaMedic Communications.

It was a great experience to land in Sydney for the GLOBALHealthPR AGM amidst some of the great healthcare communicators from around the globe.  Sitting in the conference room at Park Hyatt Sydney overlooking the Opera House and Harbour Bridge, it was the perfect setting to meet all the partners and discuss global trends in healthcare communication. I did notice that around the world there are newer challenges that the pharmaceutical and healthcare industries are facing as far as effective communication is concerned. As the globe is getting economically stronger and flatter, health issues are dynamically changing. With increasing life spans, the global population is ageing, bringing with it new challenges for elderly care. The fast-increasing incidences of Alzheimer’s, Parkinson’s, cancer and other afflictions are taking a toll on public health and highlight a dire need for early diagnosis and care. [Read more…] about Content, Context and the Future of Health Communication

Here in Sydney, we’ve just concluded our 2014 Annual General Meeting (AGM), the first to be hosted in Australia by our partners at VIVA! Communications. And, we could not be more excited about the outcomes! Early on, we got a heavy dose of local in-country updates from GLOBALHealthPR members, who reflected on accomplishments and challenges alike. Next, we used these responses to inform and refine our strategies moving forward. Our member agencies, from over a dozen countries, also shared the latest healthcare trends in their markets.

Most importantly, today is World Rare Disease Day and because of this we spent the greater part of the morning discussing the cold hard fact that medical research innovations alone cannot help patients with rare medical conditions. Our keynote speaker, David Kwasha, Managing Director of Alexion Pharmaceuticals, delivered a powerful message and queried why patients should be denied access to treatments for rare diseases. “Why should any human be discriminated against access to life-saving therapy simply because their disease is ultra-rare? Considering the majority of ultra-rare diseases are often the most life-threatening diseases seen in medicine, and commonly affect infants, children and young adults, we need much greater collaboration between government, industry and the general public in this exciting era in which science is unlocking breakthroughs,” said Mr Kwasha. He challenged partners to devise effective communications-driven strategies to address the dilemma of reimbursement for treatments for ultra-rare disease.

[Read more…] about GLOBALHealthPR Unites Down Under on World Rare Disease Day